Ulcerative Colitis (UC) is an idiopathic inflammatory disease of the large intestine that is quite common in the United States and other Western countries. Patients with UC are at greater risk of developing colorectal adenocarcinoma (AC) than the general population. However, the mechanisms involved in the UC-dysplasia- cancer sequence are still unclear. Recent clinical studies have shown that TSP-1 has an important role in AC. ApcMin+ mice that develop multiple intestinal adenomas and carcinomas have shown an increase of tumor growth and invasion when they are TSP-1 deficient. TSP-1 has key functions in inflammation, which is assumed to be the primary cause for carcinogenesis in UC. ? ? The overall objective of this project is to determine the in vivo role of thrombospondin (TSP-1) in inflammation-UC-driven colorectal carcinogenesis. Mice lacking TSP-1 and WT will be challenged using the dextran sulfate sodium (DSS) induced model for UC. Also, the therapeutics effects of TSP derived-peptides n UC will be investigated using the DSS model. This approach is a unique way to analyze in a mechanistic fashion the in vivo functions of TSP-1 in inflammation and inflammation-related carcinogenesis.
The specific aims of this study are: to analyze the temporal-spatial expression of TSP-1 on DSS -induced colitis; to characterize and grade inflammation and dysplasia UC-related in TSP-1 deficient mice; and finally, to investigate the efficacy of TSP-1 derived-peptides on inhibiting the UC inflammation-carcinogenesis progression. ? ? UC is a chronic ulceration of the intestines with an incidence of 1 in 1000 persons in western countries. Still, there is no safe treatment for this costly disease. This proposal will investigate the causes and mechanisms involved in UC in order to develop alternative therapies. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15DK067901-01A1
Application #
7012470
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Hamilton, Frank A
Project Start
2006-05-01
Project End
2010-01-30
Budget Start
2006-05-01
Budget End
2010-01-30
Support Year
1
Fiscal Year
2006
Total Cost
$223,895
Indirect Cost
Name
Wilkes University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
079158531
City
Wilkes-Barre
State
PA
Country
United States
Zip Code
18766
Lopez-Dee, Zenaida P; Chittur, Sridar V; Patel, Hiral et al. (2015) Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis. PLoS One 10:e0139918
Gutierrez, Linda S; Ling, Jun; Nye, Derek et al. (2015) Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model. World J Gastroenterol 21:6157-66
Lopez-Dee, Zenaida P; Chittur, Sridar V; Patel, Bhumi et al. (2012) Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: transcript profile and therapeutic effects. PLoS One 7:e34590
Lopez-Dee, Zenaida; Pidcock, Kenneth; Gutierrez, Linda S (2011) Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm 2011:296069
Gutierrez, Linda S (2008) The Role of Thrombospondin 1 on Intestinal Inflammation and Carcinogenesis. Biomark Insights 2008:171-178
Punekar, Salman; Zak, Samantha; Kalter, Valerie G et al. (2008) Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease. Pathobiology 75:9-21
Zak, Samantha; Treven, John; Nash, Nolly et al. (2008) Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease. Int J Colorectal Dis 23:297-304